A Phase II Multicenter Open-label Study to Assess the Efficacy of Decitabine in the Treatment of Chronic Myelomonocytic Leukemia
Phase of Trial: Phase II
Latest Information Update: 02 Jul 2018
At a glance
- Drugs Decitabine (Primary)
- Indications Chronic myelomonocytic leukaemia
- Focus Therapeutic Use
- Acronyms DECI2009
- 21 Jun 2018 Status changed from active, no longer recruiting to completed.
- 27 Feb 2018 Planned End Date changed from 1 Dec 2017 to 1 Jun 2018.
- 10 Aug 2017 Planned End Date changed from 1 Jun 2017 to 1 Dec 2017.